Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy.

Jonathan Douxfils, Jean-Michel Foidart, Ulysse Gaspard, Guillaume Chatel, Mélanie Taziaux, Maud Jost, Céline Gérard, Laure Morimont

Research output: Contribution to journalArticlepeer-review

22 Downloads (Pure)
Original languageEnglish
Pages (from-to)117-119
Number of pages3
JournalPrzeglad menopauzalny = Menopause review
Issue number2
Publication statusPublished - Jun 2023

Cite this